Home » Stocks » Zimmer Biomet

Zimmer Biomet Holdings, Inc. (ZBH)

Stock Price: $137.93 USD -0.65 (-0.47%)
Updated Aug 13, 2020 3:59 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 28.56B
Revenue (ttm) 7.03B
Net Income (ttm) 36.70M
Shares Out 207.05M
EPS (ttm) 0.18
PE Ratio 766.28
Forward PE 32.05
Dividend $0.96
Dividend Yield 0.70%

Stock Quote

Trading Day Aug 13, 2020
Last Price $137.93
Previous Close $138.58
Change ($) -0.65
Change (%) -0.47%
Day's Open 137.57
Day's Range 136.54 - 138.71
Day's Volume 587,203
52-Week Range 74.37 - 161.11

More Stats

Market Cap 28.56B
Enterprise Value 36.05B
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date Jun 26, 2020
Shares Outstanding 207.05M
Float 206.78M
EPS (basic) 0.2
EPS (diluted) 0.18
FCF / Share 4.35
Dividend $0.96
Dividend Yield 0.70%
Earnings Yield 0.13%
FCF Yield 3.15%
Payout Ratio n/a
Shares Short 2.78M
Short Ratio 2.10
Short % of Float 1.35%
Beta 1.35
PE Ratio 766.28
Forward PE 32.05
P/FCF Ratio 31.76
PS Ratio 4.06
PB Ratio 2.46
Revenue 7.03B
Operating Income -45.10M
Net Income 36.70M
Free Cash Flow 899.30M
Net Cash -7.50B
Net Cash / Share -36.20
Gross Margin 81.53%
Operating Margin -0.64%
Profit Margin 0.50%
FCF Margin 12.80%
ROA 2.24%
ROE 0.31%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (28)

Buy 18
Overweight 2
Hold 7
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$146.24*
(6.02% upside)
Low
99.0
Current: $137.93
High
175.0
Target: 146.24
*Average 12-month price target from 25 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue7,9827,9337,8037,6685,9984,6734,6234,4724,4524,220
Revenue Growth0.62%1.66%1.76%27.85%28.34%1.08%3.39%0.45%5.49%-
Gross Profit5,7305,6615,6705,2874,1973,4313,3573,3473,3303,208
Operating Income1,13833.807998214671,0371,0691,0471,024917
Net Income1,132-3791,814306147720780755761597
Shares Outstanding205204202200187169170175188200
Earnings Per Share5.47-1.868.901.510.774.204.544.294.032.97
EPS Growth--489.4%96.1%-81.67%-7.49%5.83%6.45%35.69%-
Dividend Per Share0.960.960.960.960.880.880.800.72--
Dividend Growth0%0%0%9.09%0%10%11.11%---
Operating Cash Flow1,5861,7471,5821,6328501,0619631,1521,1771,194
Capital Expenditures-721-439-493-530-364-342-293-264-269-280
Free Cash Flow8651,3081,0891,102486718670888908913
Cash & Equivalents6185435246341,6241,6961,8081,5561,224934
Total Debt8,2218,93910,14311,24111,4971,4261,6721,8211,7191,142
Net Cash / Debt-7,604-8,396-9,618-10,607-9,874270135-265-496-208
Assets24,63924,12726,01426,68427,1619,6589,5819,0128,5158,000
Liabilities12,24612,85114,27917,01517,2713,1063,2813,1463,0012,229
Book Value12,38811,27111,7369,6699,8886,5506,2975,8615,5075,771
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zimmer Biomet Holdings, Inc.
Country United States
Employees 19,900
CEO Bryan C. Hanson

Stock Information

Ticker Symbol ZBH
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: ZBH

Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.